drug
ASENAPINE
updated 4mo agoby SIGMAPHARM LABS LLC
community read0 votes
all catalysts(0)
nothing on the calendar yet
Trials studying ASENAPINE
- phase3Efficacy and Safety of Asenapine With Placebo and Olanzapine (41022)(P05947)
- phase3Efficacy and Safety of Asenapine Compared With Olanzapine in Patients With Persistent Negative Symptoms of Schizophrenia (25543)(COMPLETED)(P05817)
- phase33-week Study of Asenapine, Olanzapine and Placebo for Treatment of Bipolar Mania (P07009)
- phase2An Acceptability Study of Unflavored Asenapine Versus Raspberry Flavored Asenapine in Stable Patients With a Psychotic Disorder (P07010)(COMPLETED)
- phase3Efficacy and Safety of Asenapine With Placebo and Haloperidol (41023)(P05926)(COMPLETED)
- phase39 Week Extension Study of Asenapine and Olanzapine in Treatment of Mania (P07007)(COMPLETED)
- phase3Efficacy and Safety of Asenapine With Placebo and Olanzapine (41021)(P05933)
- phase33-Week Study of Asenapine, Olanzapine and Placebo for Treatment of Bipolar Mania (P07008)
Patent cliff
source: FDA Orange Bookfirst barrier falls
Jul 25, 2033
~6.9 years out
Earliest of all listed patents + FDA exclusivities. Generic / biosimilar entry typically only becomes possible AFTER both patent and exclusivity barriers expire.
patents (18)
- Sep 22, 2033formulationUS 11813364
- Sep 22, 2033formulationUS 11813364
- Sep 22, 2033formulationUS 11813364
- Jul 25, 2033formulationUS 10022445
- Jul 25, 2033formulationUS 10022445
- Jul 25, 2033formulationUS 10022445
- Jul 25, 2033formulationUS 10583121
- Jul 25, 2033formulationUS 10583121
- Jul 25, 2033formulationUS 10583121
- Jul 25, 2033formulationUS 10814002
- Jul 25, 2033formulationUS 10814002
- Jul 25, 2033formulationUS 10814002
- Jul 25, 2033formulationUS 11123305
- Jul 25, 2033formulationUS 11123305
- Jul 25, 2033formulationUS 11123305
- Jul 25, 2033formulationUS 9687474
- Jul 25, 2033formulationUS 9687474
- Jul 25, 2033formulationUS 9687474
News(0)
no news has mentioned this drug yet
Data sources
last refreshed 46m ago
Found something off?
comments(0)
5-min edit window · permanent after that